TriSalus Life Sciences (TLSI) Current Taxes (2022 - 2023)

TriSalus Life Sciences' (TLSI) quarterly Current Taxes came in at $30694.0 in Q2 2023, up 8.84% year-on-year from $28202.0 in Q2 2022, and down 44.16% quarter-over-quarter from $54972.0 in Q1 2023.

TriSalus Life Sciences (TLSI) Current Taxes (2022 - 2023) Analysis & Trends

TriSalus Life Sciences' Current Taxes history runs 2 years deep, the most recent figure standing at $30694.0 for Q2 2023.

  • On a quarterly basis, Current Taxes rose 8.84% year-over-year to $30694.0 in Q2 2023; TTM through Jun 2023 was $30694.0, a 8.84% increase from a year earlier, with the FY2022 full-year figure at $27854.0, changed N/A from the prior year.
  • Current Taxes eased to $30694.0 in Q2 2023 per TLSI's latest filing, from $54972.0 in the prior quarter.
  • Across five years, Current Taxes topped out at $163486.0 in Q3 2022 and bottomed at $27854.0 in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 598.00 Mn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 476.00 Mn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 914.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 231.81 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -
9 Smith & Nephew 25.80 Bn 25.22 Bn - 194.00 Mn
10 TriSalus Life Sciences 220.07 Mn 163.52 Mn 7.67 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2023 30,694.00
Mar 31, 2023 54,972.00
Dec 31, 2022 27,854.00
Sep 30, 2022 163,486.00
Jun 30, 2022 28,202.00